This inventor holds 27 USPTO granted patents, plus 2 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Merck Frosst Canada & Co., Merck Frosst Canada, Inc., Merck + Co., Inc.. Active years: 1995-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Quebec, CA (1995 - 2001)
- Dollard des Ormeaux, CA (1996 - 2006)
- Kirkland, CA (2001 - 2011)
Company Filing History:
12 out of 80 
11 out of 212 
2 out of 4,770 
Years Active: 1995-2011
Areas of Expertise:
Title: The Innovative Contributions of Richard W Friesen in Pharmaceutical Patents
Introduction: Richard W Friesen, based in Quebec, Canada, is a distinguished inventor with a remarkable portfolio comprising 27 patents. His inventions primarily focus on pharmaceutical advancements, particularly compounds that play a significant role in treating various health conditions.
Latest Patents: Among his latest innovations, Friesen has developed compounds such as pharmaceutical phenylquinoline and chromen-2-one triazole compounds. These compounds serve as leukotriene biosynthesis inhibitors, offering potential treatment avenues as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. Another significant invention includes 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles, which act as mPGES-1 inhibitors. These compounds are vital in treating pain and inflammation associated with diseases like osteoarthritis and rheumatoid arthritis, showcasing Friesen's commitment to advancing therapeutic options in the pharmaceutical field.
Career Highlights: Friesen has had a noteworthy career, having contributed his expertise to renowned companies such as Merck Frosst Canada & Co. and Merck Frosst Canada, Inc. His work has significantly influenced the development of innovative treatments that enhance patient care.
Collaborations: Throughout his career, Friesen has had the privilege of collaborating with talented professionals, including colleagues Daniel Dube and Rejean Fortin. These collaborations have played an essential role in fostering innovation and pushing the boundaries of pharmaceutical research.
Conclusion: Richard W Friesen exemplifies the spirit of innovation through his extensive work in the pharmaceutical industry. His 27 patents and ongoing research continue to pave the way for new treatments that address significant health challenges. The impact of his inventions reflects both his dedication to advancing medical science and his contribution to improving human health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile